Kaplan–Meier survival analysis demonstrated that high levels of HDAC1 (HR 1.89, 95%CI 1.35–2.64) correlated with poorer overall survival (OS) in FLT3-ITD AML patients (Fig. 3g). The gene discussed is HDAC1; the disease is acute myeloid leukemia.